Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared a post on LinkedIn:
“Heading to AHA25 in New Orleans?
Here’s where to find our team – and what we’ll cover (Central Time).
Sun, Nov 9 – 11:57 AM – 12:02 PM
Aditya Bhave, MD – Moderated Poster 19 (Clinical Science Zone 2).
Evaluating the Cardiotoxicity of Novel Antibody Drug Conjugates Compared to Standard of Care Regimens for HER2 – Positive Metastatic Breast Cancer: A Single-Arm Meta-Analysis. We present pooled data comparing HER2-targeted ADCs with standard regimens to evaluate cardiotoxicity profiles – informing safer sequencing for metastatic breast cancer. Simultaneous publication in JAMA Network Open (first author Lakshay Seth).
Sun, Nov 9 – 3:15 PM – 3:20 PM
Omar Elsayed, MD, MPH – Moderated Poster 11 (Population Science Zone).
Comparing Traditional vs Newer Definitions of Obesity in Relation to Incident Cardiovascular Disease and Cancer Risk:
Why BMI alone underestimates risk, how advanced body – composition metrics better predict cardiovascular outcomes in oncology patients.
Sun, Nov 9 – 3:15 PM – 4:15 PM
Viraj Shah, MBBS — Flatboard Poster (Population Science Zone).
Association of ACKR1 (DARC) Genotype with Cancer Risk in Participants with African Ancestry in ARIC.
Exploring ancestry – specific immune-cell trafficking variants (ACKR1/DARC) and their link to cancer risk among African-ancestry participants.
Sun, Nov 9 – 3:50 PM – 3:55 PM
Tarek Nahle, MD – Moderated Poster 10 (Population Science Zone).
Treatment Modality and Cardiovascular Mortality in Breast Cancer. A national registry analysis comparing long-term cardiovascular mortality across surgery, systemic therapy, and radiation – highlighting actionable gaps in survivorship care.
Mon, Nov 10 – 10:45 AM – 10:50 AM
Sarah Malik, MD – Moderated Poster 19 (Clinical Science Zone 2).
Use of Common Cardiovascular Medications in Cancer Survivors vs Non-Cancer Patients. Demonstrating equivalent CV risk reduction from statins, ACE/ARBs, and beta-blockers in cancer survivors – supporting full integration of guideline-directed therapy into oncology follow-up.
Mon, Nov 10 – 2:06 PM – 2:11 PM
Sathvika Narasimhan – Moderated Poster 15 (Population Science Zone).
Unequal Access: Socioeconomic Deprivation and Travel Distance to Phase III Lipid – Lowering Trials in the Southern U.S. Quantifying how geography and deprivation limit trial participation – and identifying policy and design levers to expand equitable enrollment.
More posts featuring Avirup Guha on OncoDaily.